Tan Lab | DSigDB

Gene Set: D4 : CTD - Caffeine

Collection

D4 : CTD

Chemical Name

Caffeine ( From PubChem : CAFFEINE )

FDA	NPC	WHO	Indian	Australia	China	Traditional Herbal	Clinical Trail
Approved	Not	Approved	Approved	Not	Approved	Approved	Not

Molecular Weight	Hydrogen Bond Donor Count	Hydrogen Bond Acceptor Count	cLogP	Lipinski Rule
194.191 g/mol	0	6	-1.0293	True

Structure

InChI

InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3

InChIKey

RYYVLZVUVIJVGH-UHFFFAOYSA-N

Links

Gene (115 / 305)

⊖ Less

Source	Type	Unit	Value	Gene	PMID	Other
CTD	decreases(expression)			ACAT2		D002110
CTD	increases(expression)			ACIN1		D002110
CTD	increases(expression)			ACSL3		D002110
CTD	decreases(activity)			ADORA1		D002110
CTD	affects(response to substance)			ADORA2A		D002110
CTD	increases(response to substance)			ADORA2A		D002110
CTD	increases(response to substance)			ADORA2A		D002110
CTD	decreases(activity)			ADORA2A		D002110
CTD	decreases(activity)			ADORA2B		D002110
CTD	decreases(expression)			ADORA2B		D002110
CTD	decreases(reaction)			ADORA2B		D002110
CTD	decreases(reaction)			AKT1		D002110
CTD	increases(phosphorylation)			AKT1		D002110
CTD	decreases(response to substance)			AKT1		D002110
CTD	decreases(reaction)			AKT1		D002110
CTD	increases(phosphorylation)			AKT1		D002110
CTD	decreases(expression)			AKT1		D002110
CTD	decreases(phosphorylation)			AKT1		D002110
CTD	decreases(expression)			ALDH18A1		D002110
CTD	decreases(expression)			ANG		D002110
CTD	affects(cotreatment)			APOA1		D002110
CTD	increases(expression)			APOA1		D002110
CTD	affects(cotreatment)			APOA2		D002110
CTD	decreases(expression)			APOA2		D002110
CTD	affects(cotreatment)			APOB		D002110
CTD	decreases(expression)			APOB		D002110
CTD	affects(cotreatment)			APOC1		D002110
CTD	increases(expression)			APOC1		D002110
CTD	affects(cotreatment)			APOC2		D002110
CTD	decreases(expression)			APOC2		D002110
CTD	affects(cotreatment)			APOC3		D002110
CTD	decreases(expression)			APOC3		D002110
CTD	increases(expression)			ARL6IP1		D002110
CTD	decreases(expression)			ASNS		D002110
CTD	decreases(reaction)			ATM		D002110
CTD	increases(phosphorylation)			ATM		D002110
CTD	decreases(reaction)			ATM		D002110
CTD	increases(activity)			ATM		D002110
CTD	decreases(activity)			ATM		D002110
CTD	decreases(reaction)			ATM		D002110
CTD	increases(phosphorylation)			ATM		D002110
CTD	decreases(reaction)			ATM		D002110
CTD	increases(phosphorylation)			ATM		D002110
CTD	decreases(reaction)			ATM		D002110
CTD	increases(phosphorylation)			ATM		D002110
CTD	affects(cotreatment)			ATM		D002110
CTD	decreases(reaction)			ATM		D002110
CTD	increases(activity)			ATM		D002110
CTD	decreases(activity)			ATM		D002110
CTD	affects(cotreatment)			ATM		D002110
CTD	decreases(activity)			ATM		D002110
CTD	decreases(response to substance)			ATM		D002110
CTD	decreases(expression)			ATP5J2		D002110
CTD	affects(activity)			ATR		D002110
CTD	decreases(reaction)			ATR		D002110
CTD	increases(activity)			ATR		D002110
CTD	increases(phosphorylation)			ATR		D002110
CTD	increases(reaction)			ATR		D002110
CTD	affects(cotreatment)			ATR		D002110
CTD	decreases(reaction)			ATR		D002110
CTD	increases(activity)			ATR		D002110
CTD	affects(cotreatment)			ATR		D002110
CTD	decreases(activity)			ATR		D002110
CTD	decreases(response to substance)			ATR		D002110
CTD	increases(expression)			BAX		D002110
CTD	decreases(reaction)			BBC3		D002110
CTD	increases(expression)			BBC3		D002110
CTD	decreases(reaction)			BID		D002110
CTD	increases(cleavage)			BID		D002110
CTD	affects(cotreatment)			BUB1		D002110
CTD	increases(expression)			BUB1		D002110
CTD	decreases(expression)			CALU		D002110
CTD	affects(cotreatment)			CAPN1		D002110
CTD	increases(activity)			CAPN1		D002110
CTD	increases(reaction)			CAPN1		D002110
CTD	decreases(reaction)			CASP2		D002110
CTD	increases(activity)			CASP2		D002110
CTD	increases(cleavage)			CASP2		D002110
CTD	affects(cleavage)			CASP3		D002110
CTD	affects(cotreatment)			CASP3		D002110
CTD	increases(cleavage)			CASP3		D002110
CTD	decreases(reaction)			CASP3		D002110
CTD	increases(activity)			CASP3		D002110
CTD	decreases(reaction)			CASP3		D002110
CTD	increases(activity)			CASP3		D002110
CTD	increases(cleavage)			CASP3		D002110
CTD	increases(activity)			CASP3		D002110
CTD	increases(cleavage)			CASP3		D002110
CTD	increases(expression)			CASP3		D002110
CTD	decreases(reaction)			CASP9		D002110
CTD	increases(activity)			CASP9		D002110
CTD	increases(cleavage)			CASP9		D002110
CTD	increases(cleavage)			CASP9		D002110
CTD	increases(expression)			CASP9		D002110
CTD	decreases(reaction)			CCNB1		D002110
CTD	increases(expression)			CCNB1		D002110
CTD	affects(binding)			CDC25C		D002110
CTD	decreases(reaction)			CDC25C		D002110
CTD	decreases(reaction)			CDC25C		D002110
CTD	increases(phosphorylation)			CDC25C		D002110
CTD	decreases(expression)			CDC25C		D002110
CTD	decreases(reaction)			CDK1		D002110
CTD	increases(phosphorylation)			CDK1		D002110
CTD	decreases(reaction)			CDK1		D002110
CTD	increases(phosphorylation)			CDK1		D002110
CTD	decreases(phosphorylation)			CDK1		D002110
CTD	increases(activity)			CDK1		D002110
CTD	decreases(activity)			CDK2		D002110
CTD	decreases(expression)			CDK4		D002110
CTD	decreases(reaction)			CDKN1A		D002110
CTD	increases(expression)			CDKN1A		D002110
CTD	decreases(reaction)			CDKN1A		D002110
CTD	increases(expression)			CDKN1A		D002110
CTD	decreases(reaction)			CDKN1A		D002110
CTD	increases(expression)			CDKN1A		D002110
CTD	decreases(reaction)			CDKN1A		D002110
CTD	increases(expression)			CDKN1A		D002110
CTD	decreases(reaction)			CDKN1A		D002110
CTD	increases(expression)			CDKN1A		D002110
CTD	decreases(reaction)			CHEK1		D002110
CTD	increases(activity)			CHEK1		D002110
CTD	increases(phosphorylation)			CHEK1		D002110
CTD	decreases(reaction)			CHEK1		D002110
CTD	increases(activity)			CHEK1		D002110
CTD	increases(phosphorylation)			CHEK1		D002110
CTD	increases(reaction)			CHEK1		D002110
CTD	affects(cotreatment)			CHEK1		D002110
CTD	decreases(reaction)			CHEK1		D002110
CTD	increases(activity)			CHEK1		D002110
CTD	decreases(phosphorylation)			CHEK1		D002110
CTD	decreases(reaction)			CHEK2		D002110
CTD	increases(phosphorylation)			CHEK2		D002110
CTD	decreases(reaction)			CHEK2		D002110
CTD	increases(phosphorylation)			CHEK2		D002110
CTD	affects(cotreatment)			CHEK2		D002110
CTD	decreases(reaction)			CHEK2		D002110
CTD	increases(activity)			CHEK2		D002110
CTD	decreases(reaction)			CHEK2		D002110
CTD	increases(phosphorylation)			CHEK2		D002110
CTD	increases(activity)			CHEK2		D002110
CTD	increases(phosphorylation)			CHEK2		D002110
CTD	increases(reaction)			CHEK2		D002110
CTD	decreases(activity)			CHEK2		D002110
CTD	affects(cotreatment)			CTSB		D002110
CTD	increases(secretion)			CTSB		D002110
CTD	decreases(expression)			CYC1		D002110
CTD	affects(localization)			CYCS		D002110
CTD	decreases(reaction)			CYCS		D002110
CTD	decreases(activity)			CYP1A2		D002110
CTD	decreases(methylation)			CYP1A2		D002110
CTD	decreases(reaction)			CYP1A2		D002110
CTD	affects(metabolic processing)			CYP1A2		D002110
CTD	affects(metabolic processing)			CYP1A2		D002110
CTD	affects(binding)			CYP1A2		D002110
CTD	affects(metabolic processing)			CYP1A2		D002110
CTD	affects(binding)			CYP1A2		D002110
CTD	decreases(methylation)			CYP1A2		D002110
CTD	increases(metabolic processing)			CYP1A2		D002110
CTD	increases(metabolic processing)			CYP1A2		D002110
CTD	increases(reaction)			CYP1A2		D002110
CTD	increases(metabolic processing)			CYP1A2		D002110
CTD	increases(reaction)			CYP1A2		D002110
CTD	decreases(reaction)			CYP1A2		D002110
CTD	increases(metabolic processing)			CYP1A2		D002110
CTD	affects(metabolic processing)			CYP2A6		D002110
CTD	increases(activity)			CYP2A6		D002110
CTD	increases(metabolic processing)			CYP2A6		D002110
CTD	affects(metabolic processing)			CYP2D6		D002110
CTD	affects(metabolic processing)			CYP2E1		D002110
CTD	decreases(activity)			CYP3A4		D002110
CTD	increases(expression)			CYP4B1		D002110
CTD	decreases(expression)			DAD1		D002110
CTD	increases(expression)			DCT		D002110
CTD	affects(response to substance)			DRD2		D002110
CTD	increases(expression)			EIF1		D002110
CTD	decreases(expression)			EIF4EBP1		D002110
CTD	increases(expression)			EIF4EBP1		D002110
CTD	increases(metabolic processing)			GH1		D002110
CTD	increases(reaction)			GH1		D002110
CTD	decreases(expression)			GLRX		D002110
CTD	decreases(expression)			GLT8D1		D002110
CTD	decreases(expression)			GLUD1		D002110
CTD	increases(phosphorylation)			GSK3B		D002110
CTD	decreases(reaction)			GSK3B		D002110
CTD	decreases(expression)			GSTO1		D002110
CTD	decreases(reaction)			H2AFX		D002110
CTD	increases(phosphorylation)			H2AFX		D002110
CTD	decreases(reaction)			H2AFX		D002110
CTD	increases(phosphorylation)			H2AFX		D002110
CTD	decreases(reaction)			H2AFX		D002110
CTD	increases(phosphorylation)			H2AFX		D002110
CTD	increases(phosphorylation)			H2AFX		D002110
CTD	increases(reaction)			H2AFX		D002110
CTD	decreases(activity)			HSD11B2		D002110
CTD	decreases(expression)			HSD11B2		D002110
CTD	decreases(reaction)			HSD11B2		D002110
CTD	increases(expression)			IGFBP1		D002110
CTD	decreases(reaction)			INS		D002110
CTD	increases(phosphorylation)			INS		D002110
CTD	decreases(expression)			ITPR1		D002110
CTD	decreases(expression)			LDHA		D002110
CTD	increases(expression)			MAPK1		D002110
CTD	increases(expression)			MAPK3		D002110
CTD	decreases(expression)			MGST1		D002110
CTD	decreases(methylation)			MICB		D002110
CTD	decreases(reaction)			MICB		D002110
CTD	increases(expression)			MICB		D002110
CTD	increases(expression)			MT1G		D002110
CTD	decreases(activity)			MTOR		D002110
CTD	affects(metabolic processing)			NAT2		D002110
CTD	affects(metabolic processing)			NAT2		D002110
CTD	increases(acetylation)			NAT2		D002110
CTD	increases(expression)			OAT		D002110
CTD	increases(activity)			PAK2		D002110
CTD	affects(cleavage)			PARP1		D002110
CTD	affects(cotreatment)			PARP1		D002110
CTD	increases(activity)			PARP1		D002110
CTD	increases(activity)			PARP1		D002110
CTD	increases(cleavage)			PARP1		D002110
CTD	increases(reaction)			PARP1		D002110
CTD	increases(cleavage)			PARP1		D002110
CTD	increases(expression)			PARP1		D002110
CTD	increases(cleavage)			PARP1		D002110
CTD	increases(expression)			PLP1		D002110
CTD	decreases(expression)			PPP2R2B		D002110
CTD	decreases(expression)			PRELID1		D002110
CTD	increases(activity)			PRKDC		D002110
CTD	increases(phosphorylation)			PRKDC		D002110
CTD	increases(reaction)			PRKDC		D002110
CTD	decreases(expression)			PRNP		D002110
CTD	decreases(expression)			PSME3		D002110
CTD	decreases(expression)			PTGS2		D002110
CTD	decreases(phosphorylation)			RB1		D002110
CTD	increases(activity)			REN		D002110
CTD	decreases(expression)			RPS6		D002110
CTD	decreases(expression)			RPS6KA3		D002110
CTD	decreases(expression)			RPS6KB1		D002110
CTD	increases(expression)			RRS1		D002110
CTD	increases(activity)			RYR1		D002110
CTD	affects(localization)			RYR1		D002110
CTD	increases(response to substance)			RYR1		D002110
CTD	increases(response to substance)			RYR1		D002110
CTD	affects(reaction)			RYR1		D002110
CTD	increases(secretion)			RYR1		D002110
CTD	decreases(expression)			SCFD1		D002110
CTD	decreases(expression)			SEC13		D002110
CTD	decreases(expression)			SEC23A		D002110
CTD	increases(expression)			SERPINA1		D002110
CTD	decreases(expression)			SERPINA6		D002110
CTD	affects(reaction)			SLC16A1		D002110
CTD	increases(uptake)			SLC16A1		D002110
CTD	increases(expression)			SLC16A1		D002110
CTD	increases(expression)			SMOX		D002110
CTD	decreases(expression)			SQLE		D002110
CTD	decreases(reaction)			SQSTM1		D002110
CTD	increases(degradation)			SQSTM1		D002110
CTD	decreases(expression)			SQSTM1		D002110
CTD	decreases(expression)			SRSF1		D002110
CTD	decreases(methylation)			STAR		D002110
CTD	increases(expression)			STAR		D002110
CTD	decreases(expression)			STRBP		D002110
CTD	decreases(expression)			TFDP1		D002110
CTD	decreases(expression)			TM9SF1		D002110
CTD	increases(expression)			TMCC2		D002110
CTD	decreases(expression)			TMEM97		D002110
CTD	increases(expression)			TNFSF4		D002110
CTD	decreases(reaction)			TP53		D002110
CTD	increases(phosphorylation)			TP53		D002110
CTD	decreases(reaction)			TP53		D002110
CTD	increases(expression)			TP53		D002110
CTD	increases(phosphorylation)			TP53		D002110
CTD	decreases(reaction)			TP53		D002110
CTD	increases(phosphorylation)			TP53		D002110
CTD	decreases(reaction)			TP53		D002110
CTD	increases(activity)			TP53		D002110
CTD	increases(phosphorylation)			TP53		D002110
CTD	decreases(reaction)			TP53		D002110
CTD	increases(expression)			TP53		D002110
CTD	increases(phosphorylation)			TP53		D002110
CTD	decreases(reaction)			TP53		D002110
CTD	increases(expression)			TP53		D002110
CTD	decreases(reaction)			TP53		D002110
CTD	increases(phosphorylation)			TP53		D002110
CTD	decreases(reaction)			TP53		D002110
CTD	increases(phosphorylation)			TP53		D002110
CTD	decreases(reaction)			TP53		D002110
CTD	increases(expression)			TP53		D002110
CTD	decreases(reaction)			TP53		D002110
CTD	increases(phosphorylation)			TP53		D002110
CTD	increases(phosphorylation)			TP53		D002110
CTD	decreases(expression)			TXNRD1		D002110
CTD	increases(expression)			UGT1A1		D002110
CTD	decreases(expression)			UQCRC2		D002110
CTD	affects(metabolic processing)			XDH		D002110
CTD	affects(binding)			YWHAQ		D002110
CTD	decreases(reaction)			YWHAQ		D002110
CTD	increases(expression)			ZNF37A		D002110
PubChem	Potency-Replicate_1	uM	49.151	AR	-	GI(Protien) :
PubChem	Ratio Potency (uM)	uM	8.095	NFE2L2	-	GI(Protien) :
ChEMBL	Inhibition	-		CYP1A2	-	Target : CHEMBL3356
ChEMBL	Inhibition	-		CYP2C19	-	Target : CHEMBL3622
ChEMBL	Inhibition	-		CYP2C9	-	Target : CHEMBL3397
ChEMBL	Inhibition	-		CYP2D6	-	Target : CHEMBL289
ChEMBL	Inhibition	-		CYP3A4	-	Target : CHEMBL340
ChEMBL	Inhibition	-		CYP3A4	-	Target : CHEMBL340

Download gene sets

gmt, text, Detailed text